Hazard ratios were adjusted for age, race, sex, Framingham Risk Score, baseline systolic and diastolic blood pressure, use of antihypertensive medication before randomization, smoking status, aspirin use, estimated glomerular filtration rate, history of clinical/subclinical cardiovascular disease, total cholesterol, high-density lipoprotein, triglycerides, glucose, urine albumin/creatinine ratio, body-mass index, statin use, number of antihypertensive medications used, visit adherence, and estimated achieved 1-year SBP. All interactions were not significant for visit-to-visit variability class and each outcome except for heart failure in SPRINT (class 2 vs class 1 [p=0.062], and class 3 vs class 1 [p=0.088]).
